Clinical trial
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
NCT04477785
Study timeline
Study start (actual)2020-07-01Date precision: day
Registry last updated2026-07-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Parkinson Diseaseunresolved
Interventions
Sponsors & collaborators
Institute for Neurodegenerative Disorderscollaborator
Mapped research locations
New YorkNew York, United States2BostonMassachusetts, United States2HoustonTexas, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1BaltimoreMaryland, United States1AtlantaGeorgia, United States1TorontoOntario, Canada1San FranciscoCalifornia, United States1LondonUnited Kingdom1SeattleWashington, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04477785 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.